We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

193 hedge funds and large institutions have $1.23B invested in Ariad Pharmaceuticals Inc in 2015 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 24

38% more capital invested

Capital invested by funds: $888M → $1.23B (+$341M)

8% more funds holding

Funds holding: 179 → 193 (+14)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

5% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 62

31% less call options, than puts

Call options by funds: $19M | Put options by funds: $27.6M

Holders
193
Holders Change
+14
Holders Change %
+7.82%
% of All Funds
5.14%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
39
Increased
59
Reduced
62
Closed
24
Calls
$19M
Puts
$27.6M
Net Calls
-$8.59M
Net Calls Change
-$5.84M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$53.8M
2
DCM
Discovery Capital Management
Connecticut
+$43.2M
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.7M
4
Invesco
Invesco
Georgia
+$15.3M
5
Millennium Management
Millennium Management
New York
+$11.1M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9.13M
2
CCI
Columbus Circle Investors
-$6.91M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.88M
4
PC
PointState Capital
New York
-$6.65M
5
Ameriprise
Ameriprise
Minnesota
-$4.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
151
US Bancorp
Minnesota
$112K -$32.9K -4,452 -25%
SCM
152
Stevens Capital Management
Pennsylvania
$109K +$97.9K +13,240 New
N
153
Nuveen
North Carolina
$105K – – –
LPL Financial
154
LPL Financial
California
$103K -$35K -4,741 -27%
SI
155
SII Investments
Wisconsin
$100K +$90.9K +12,300 New
POA
156
Pergamon Offshore Advisors
New York
$96K +$86K +11,628 New
Canada Life
157
Canada Life
Manitoba, Canada
$87K – – –
FDCC
158
Foster Dykema Cabot & Co
Massachusetts
$84K – – –
CCMH
159
Cornerstone Capital Management Holdings
New York
$65K +$32.5K +4,400 +126%
Creative Planning
160
Creative Planning
Kansas
$63K -$13.8K -1,860 -20%
QT
161
Quantbot Technologies
New York
$62K +$56.4K +7,634 New
Teacher Retirement System of Texas
162
Teacher Retirement System of Texas
Texas
$44K +$67 +9 +0.2%
Bank of Montreal
163
Bank of Montreal
Ontario, Canada
$42K -$39.2K -5,300 -51%
RIA
164
Regal Investment Advisors
Michigan
$41K – – –
BlackRock
165
BlackRock
New York
$40K – – –
PCM
166
Prelude Capital Management
New York
$36K -$411K -55,600 -93%
BNP Paribas Financial Markets
167
BNP Paribas Financial Markets
France
$32.2K +$28.9K +3,911 New
RAM
168
Riggs Asset Management
Pennsylvania
$27K – – –
EWM
169
Edge Wealth Management
New York
$25K -$3.7K -500 -14%
Schroder Investment Management Group
170
Schroder Investment Management Group
United Kingdom
$25K – – –
SEC
171
Seven Eight Capital
New York
$21K +$18.5K +2,500 +9,615%
MFS
172
MSI Financial Services
Massachusetts
$17K +$5.54K +750 +56%
IMS
173
Index Management Solutions
Pennsylvania
$16K +$14.1K +1,908 New
RFC
174
Russell Frank Company
Washington
$15K – – –
Simplex Trading
175
Simplex Trading
Illinois
$15K +$14K +1,890 New
5 6
7
8 9

ARIA Hedge Fund Activity: Q1 2015 in Review

193 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2015, worth a combined $1.23B — up 38% from $888M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ARIA positions and 24 closed out — a net gain of 15 holders — while 59 added to existing stakes and 62 trimmed.

The largest buyer was Putnam Investments, adding an estimated $53.8M. The largest seller was Susquehanna International Group, cutting an estimated $9.13M.

  • 193 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2015, up from 179 in Q4 2014.
  • Funds reported $1.23B of Ariad Pharmaceuticals Inc stock for Q1 2015, up 38% quarter-over-quarter.
  • 39 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2015 and 24 closed out, a net change of +15 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2015 was Putnam Investments, an estimated $53.8M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2015 was Susquehanna International Group, an estimated $9.13M sold.

Based on aggregated 13F filings for Q1 2015.